With a market capitalization (market cap) of $1.05B — a measure of how much the company is worth — AdaptHealth Corp. ranks #2,417 among the 2,444 companies tracked, and 355th in Healthcare as of November 11, 2026. Shares trade at $7.72, up 5.03% on the day.
As of November 11, 2026 · Prices may be delayed
of 2,444 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series and can differ when the share count changes. Returns below show the total change over each period. Use the CAGR calculator to calculate an annualized return. CAGR calculator. Market cap vs. stock price.
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation November 4, 2026. The headline market cap is from the ranking update on November 11, 2026.
| Year | As of | Market cap | Annual change | Share-price close |
|---|---|---|---|---|
| 2026Latest available | Nov 4, 2026 | $977.41M | -27.73% | $7.46 |
| 2025 | Dec 31, 2025 | $1.35B | +5.38% | $9.96 |
| 2024 | Dec 31, 2024 | $1.28B | +32.37% | $9.52 |
| 2023 | Dec 29, 2023 | $969.5M | -62.40% | $7.29 |
Ranking figure $1.05B as of November 11, 2026.
Market cap = share price × shares outstanding.
AdaptHealth Corp.'s ranking market cap is the reported market cap from the latest ranking update, with a share price of $7.73 as of November 11, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $977.41M on November 4, 2026. See how the ranking works.
The ranking snapshot ($1.05B as of November 11, 2026) is FMP company-screener market cap. The historical observation ($977.41M on November 4, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap agrees with the ranking snapshot. This page does not replace one series with the other.
Current shares outstanding are unavailable from the latest quote. Shares outstanding vs. float.
The latest annual report (FY 2025) used a weighted-average 135,146,000 shares. That figure is an average for the year, not the live count in the market-cap formula.
Book equity: assets minus liabilities on the latest annual report.
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Quote as of . Prices may be delayed. Day figures refer to the quote's trading session.
Latest quote: $7.73. The headline price of $7.72 is from the ranking update on Nov 11, 2026. These updates can differ in timing.
Largest U.S.-listed companies in the same sector. These companies may serve different markets.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #11 | Eli Lilly and Company LLY | $1.35T | +1.44% |
| #19 | Johnson & Johnson JNJ | $675.92B | -0.47% |
| #23 |
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps.
Summary from the company profile (Financial Modeling Prep). Principal financial figures above are for FY 2025.
Visit websiteAs of November 11, 2026, AdaptHealth Corp. (AHCO) is worth $1.05B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. For FY 2025, AdaptHealth Corp.’s book equity is about $1.53B. Market cap is the market value of the outstanding shares. As of November 11, 2026, its market cap is $1.05B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
AdaptHealth Corp. ranks #2,417 among the 2,444 companies tracked on MarketCapLens. In Healthcare it ranks #355 of 357.
Financial figures are annual and labeled with their fiscal year (FY). Current-price P/E uses the latest available share price and annual earnings per share.
| 2022 | Dec 30, 2022 | $2.58B | -21.35% | $19.22 |
|---|
| 2021 | Dec 31, 2021 | $3.28B | — | $24.46 |
|---|
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
FY 2025
Return on equity data unavailable for FY 2025
FY 2025
Return on assets data unavailable for FY 2025
FY 2025
| $519.48B |
| +0.20% |
| #30 | Merck & Co., Inc. MRK | $364.98B | -0.48% |
| #31 | UnitedHealth Group Incorporated UNH | $363B | +1.89% |
| #37 | Novartis AG NVS | $308.34B | -0.26% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #2414 | Hotel101 Global Holdings Corp. HBNB | $1.06B | -2.59% |
| #2415 | Dauch Corp. DCH | $1.06B | -3.26% |
| #2416 | Business First Bancshares, Inc. BFST | $1.06B | -0.18% |
| #2418 | Myers Industries, Inc. MYE | $1.05B | -0.99% |
| #2419 | USA Rare Earth Inc USAR | $1.05B | -9.59% |
| #2420 | Cryoport, Inc. CYRX | $1.05B | +1.32% |
AdaptHealth Corp.’s ranking market cap of $1.05B comes from the same snapshot as the rest of this site, as of November 11, 2026. It is not share price multiplied by the FY 2025 weighted-average share count of 135,146,000. The ranking snapshot ($1.05B as of November 11, 2026) is FMP company-screener market cap. The historical observation ($977.41M on November 4, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap agrees with the ranking snapshot. This page does not replace one series with the other.
Over the past year, AdaptHealth Corp.’s market cap is down 32.36%, using historical market-cap records rather than today’s share count applied to past prices.
AdaptHealth Corp. (AHCO) shares trade at $7.72, up 5.03% on the day, as of November 11, 2026.
Live P/E is share price divided by annual earnings per share. It is blank when earnings are missing, zero, or negative — not a 0× multiple.